HUTCHMED (China) (HCM) Current Deferred Revenue (2015 - 2025)

HUTCHMED (China) (HCM) has 11 years of Current Deferred Revenue data on file, last reported at $6.6 million in Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $6.6 million, down 47.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.6 million (down 47.69% YoY), and the FY2025 annual result was $31.4 million, up 220.99% from the prior year.
• Current Deferred Revenue eased to $6.6 million in Q4 2025 per HCM's latest filing, from $46.8 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $16.3 billion in Q4 2023 and troughed at $1.7 million in Q4 2022.
• A 5-year average of $2.1 billion and a median of $29.8 million in 2025 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue surged 939994.2% in 2023, then slumped 99.92% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $11.1 million in 2021, then slumped by 84.37% to $1.7 million in 2022, then surged by 939994.2% to $16.3 billion in 2023, then tumbled by 99.92% to $12.7 million in 2024, then plunged by 47.69% to $6.6 million in 2025.
• Business Quant data shows HCM's Current Deferred Revenue at $6.6 million in Q4 2025, $46.8 million in Q2 2025, and $12.7 million in Q4 2024.